Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05075577
Title EPI-7386 in Combination With Enzalutamide Compared With Enzalutamide Alone in Subjects With mCRPC
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors ESSA Pharmaceuticals
Indications

prostate adenocarcinoma

Therapies

Enzalutamide + EPI-7386

Enzalutamide

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.